Li Di
- Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism 67
- Pharmaceutical Science top 0.5%
- Computational Theory and Mathematics top 0.2%
- Computational Drug Discovery Methods 31
- Oncology top 1%
- Drug Transport and Resistance Mechanisms 52
- Spectroscopy top 1%
- Analytical Chemistry and Chromatography 15
-
- Pharmacological Effects and Toxicity Studies 11
-
- Myasthenia Gravis and Thymoma 10
-
- Statistical Methods in Clinical Trials 9
-
- Protein Interaction Studies and Fluorescence Analysis 9
- Co-authors
- Edward H. KernsDennis A. SmithTristan S. MaurerNicholas A. MeanwellJarkko RautioMichael J. HagemanTakashi ManoPaul V. Fish
- Journals
- Drug Metabolism and Disposition (22 papers)Journal of Pharmaceutical Sciences (16 papers)The AAPS Journal (14 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Li Di
176 papers receiving 8.4k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Pharmacology 1.7k
- Pharmaceutical Science 646
- Computational Theory and Mathematics 1.5k
- Oncology 2.1k
- Spectroscopy 845
Countries citing papers authored by Li Di
This map shows the geographic impact of Li Di's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Di with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Di more than expected).
Fields of papers citing papers by Li Di
This network shows the impact of papers produced by Li Di. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Di. The network helps show where Li Di may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Li Di, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 4 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 26 | |
| 12 | 2022 | 77 | |
| 13 | 2022 | 6 | |
| 14 | 2018 | 5 | |
| 15 | The effects of CLP-19 on inflammatory factors regulation in RAW264.7 cells | 2013 | 1 |
| 16 | 2012 | 24 | |
| 17 | 2011 | 114 | |
| 18 | 2006 | 49 | |
| 19 | A study on tissue culture technique of Populus nigra var thevestina×( P. diversifolia + P. tomentosa) | 2002 | 1 |
| 20 | CIMICIFUGAMIDE AND ISOCIMICIFUGAMIDE,TWO NEW CINNAMAMIDE DERIVATIVES ISOLATED FROM CIMICIFUGA DAHURICA | 1993 | 0 |
About Li Di
Li Di is a scholar working on Pharmacology, Oncology and Computational Theory and Mathematics, having authored 184 papers that have together received 8.6k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (67 papers), Drug Transport and Resistance Mechanisms (52 papers), Computational Drug Discovery Methods (31 papers), Analytical Chemistry and Chromatography (15 papers), Pharmacological Effects and Toxicity Studies (11 papers), Myasthenia Gravis and Thymoma (10 papers), Statistical Methods in Clinical Trials (9 papers) and Protein Interaction Studies and Fluorescence Analysis (9 papers). The work is most often cited by research in Pharmacology (1.7k citations), Pharmaceutical Science (646 citations) and Computational Theory and Mathematics (1.5k citations). Li Di has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Edward H. Kerns, Dennis A. Smith, Tristan S. Maurer, Nicholas A. Meanwell, Jarkko Rautio, Michael J. Hageman, Takashi Mano, Paul V. Fish, Kevin Beaumont and Bo Feng. Their work appears in journals such as Drug Metabolism and Disposition, Journal of Pharmaceutical Sciences, The AAPS Journal, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.